Charles River Laboratories (CRL) Tops Q1 EPS by 21c; offers guidance

Go back to Charles River Laboratories (CRL) Tops Q1 EPS by 21c; offers guidance

Charles River Labs (CRL) PT Lowered to $265 at Evercore ISI

May 9, 2024 4:15 PM EDT

Evercore ISI analyst Elizabeth Anderson lowered the price target on Charles River Labs (NYSE: CRL) to $265.00 (from $300.00) while maintaining a Outperform rating.

The analyst comments "Todays print pointed to signs of a nascent recovery. Manufacturing saw positive momentum in 1Q (typically a leading... More